OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
January 26, 2021
Patient Assistance Programs (PAPs) came out of the shadows in 2020 as several factors aligned that increased demand and awareness of these programs.
January 05, 2021
Taking a closer look at the evolving legal treatment of coupons and copay accumulators.
December 15, 2020
Outlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
December 11, 2020
2020 has proven to be a year like no other for pharma. Here is a quick look back at some of the trends 2020 created for the industry.
December 09, 2020
If telehealth is here to stay, how is the industry adjusting?
December 03, 2020
How technology can maximize use of manufacturer copay and patient assistance programs.
November 16, 2020
The importance of life sciences companies focused on rare diseases to take early steps to bridge connections with patients, caregivers, and healthcare providers.
A check on the evolving challenges and potential solutions in steering future market adoption of curative-intended treatments.
November 12, 2020
Following a year which saw a 143% increase in launched biosimilars in the US, here are three reasons why payers will drive adoption further in 2021.
November 02, 2020
Rasim Shah talks about how the application of AI to Pricing and Reimbursement can dramatically free up time spent on crunching datasets, modeling scenarios, and building price predictions.